This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

SYST-EUR study

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This study tests the efficacy of using a calcium channel blocker in elderly patients with isolated systemic hypertension. The study involves 4,695 patients from 198 centres in Europe. Participants in the trial were randomised to nitrendipine or placebo; enalapril or hydrochlorthiazide could be added if required - however most patients on nitrendipine remained on monotherapy during the study.

The use of nitrendipine cut the risk of stroke by 42% compared with placebo. There were also reductions in risk of cardiovascular events (fatal and non-fatal) by 29%, for fatal MI (56%). There was a non-significant reduction (14%) in all-cause mortality.

Reference:

  • Medical Monitor (3/9/97), 3.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.